DK542089D0 - Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf - Google Patents
Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling derafInfo
- Publication number
- DK542089D0 DK542089D0 DK542089A DK542089A DK542089D0 DK 542089 D0 DK542089 D0 DK 542089D0 DK 542089 A DK542089 A DK 542089A DK 542089 A DK542089 A DK 542089A DK 542089 D0 DK542089 D0 DK 542089D0
- Authority
- DK
- Denmark
- Prior art keywords
- solution
- acid
- benzylpenicilloic
- mdm
- benzylpenilloic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000243 solution Substances 0.000 abstract 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 4
- HCYWNSXLUZRKJX-RWMBFGLXSA-N benzylpenicilloic acid Chemical compound N1[C@@H](C(O)=O)C(C)(C)S[C@@H]1[C@@H](C(O)=O)NC(=O)CC1=CC=CC=C1 HCYWNSXLUZRKJX-RWMBFGLXSA-N 0.000 abstract 4
- LRWFMQCGNBOTQP-OLZOCXBDSA-N benzylpenilloic acid Chemical compound N1[C@@H](C(O)=O)C(C)(C)S[C@@H]1CNC(=O)CC1=CC=CC=C1 LRWFMQCGNBOTQP-OLZOCXBDSA-N 0.000 abstract 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- -1 alkali metal salt Chemical class 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000006179 pH buffering agent Substances 0.000 abstract 2
- 235000019371 penicillin G benzathine Nutrition 0.000 abstract 2
- 229940056360 penicillin g Drugs 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 229930182555 Penicillin Natural products 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9446—Antibacterials
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26574988A | 1988-11-01 | 1988-11-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK542089D0 true DK542089D0 (da) | 1989-10-31 |
| DK542089A DK542089A (da) | 1990-05-02 |
Family
ID=23011751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK542089A DK542089A (da) | 1988-11-01 | 1989-10-31 | Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0367090B1 (da) |
| AT (1) | ATE100210T1 (da) |
| DE (1) | DE68912270T2 (da) |
| DK (1) | DK542089A (da) |
| ES (1) | ES2048263T3 (da) |
| IE (1) | IE60788B1 (da) |
| PT (1) | PT92163B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT1588U1 (de) * | 1994-04-27 | 1997-08-25 | Mahl Christian Dr | Verfahren zur herstellung von testsubstanzen für verfahren mit erfassung elektromagnetischer schwingungen |
| EP3087991A1 (en) * | 2003-11-08 | 2016-11-02 | Prothera Biologics | Composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| CN106928346B (zh) | 2008-05-28 | 2021-09-07 | 普罗瑟拉生物公司 | 来自血液的间-α抑制物蛋白的制备和组合物 |
| WO2014039987A2 (en) | 2012-09-09 | 2014-03-13 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
| HK1217633A1 (zh) * | 2013-01-15 | 2017-01-20 | Teva Pharmaceutical Industries Ltd. | 冻乾方法 |
| CA2896793A1 (en) | 2013-01-15 | 2014-07-24 | Teva Pharmaceutical Industries Ltd. | Formulations of albu-bche, preparation and uses thereof |
| CN106187934A (zh) * | 2016-07-08 | 2016-12-07 | 上海上药新亚药业有限公司 | 一种羧苄西林钠杂质g的合成方法 |
| WO2018053029A1 (en) | 2016-09-13 | 2018-03-22 | Prothera Biologics, Inc. | Methods for treating pulmonary disease using inter-alpha inhibitor proteins |
| BR112019022358A2 (pt) | 2017-04-25 | 2020-05-19 | Prothera Biologics, Inc. | métodos para quantificar proteínas inibidoras inter-alfa |
| US20180326095A1 (en) * | 2017-05-11 | 2018-11-15 | AllerQuest LLC | Kits and methods to detect penicillin allergy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4316882A (en) * | 1978-04-20 | 1982-02-23 | Levine Bernard B | Compositions for testing to predict and/or diagnose allergy to penicillins |
| US4183910A (en) * | 1978-04-20 | 1980-01-15 | Levine Bernard B | Method for testing to predict and/or diagnose allergy to penicillins, and compounds and compositions for use in such tests |
| JPS63174927A (ja) * | 1987-01-14 | 1988-07-19 | Tanabe Seiyaku Co Ltd | 抗菌性凍結乾燥製剤 |
-
1989
- 1989-10-25 EP EP89119819A patent/EP0367090B1/en not_active Expired - Lifetime
- 1989-10-25 DE DE89119819T patent/DE68912270T2/de not_active Expired - Lifetime
- 1989-10-25 ES ES89119819T patent/ES2048263T3/es not_active Expired - Lifetime
- 1989-10-25 AT AT89119819T patent/ATE100210T1/de not_active IP Right Cessation
- 1989-10-30 IE IE339789A patent/IE60788B1/en not_active IP Right Cessation
- 1989-10-31 PT PT92163A patent/PT92163B/pt not_active IP Right Cessation
- 1989-10-31 DK DK542089A patent/DK542089A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE893397L (en) | 1990-05-01 |
| DE68912270D1 (de) | 1994-02-24 |
| EP0367090B1 (en) | 1994-01-12 |
| DK542089A (da) | 1990-05-02 |
| ES2048263T3 (es) | 1994-03-16 |
| PT92163A (pt) | 1990-05-31 |
| IE60788B1 (en) | 1994-08-10 |
| DE68912270T2 (de) | 1994-04-28 |
| PT92163B (pt) | 1995-07-18 |
| ATE100210T1 (de) | 1994-01-15 |
| EP0367090A1 (en) | 1990-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0618807B1 (en) | A stabilized pharmaceutical formulation comprising growth hormone and histidine | |
| US5849700A (en) | Pharmaceutical formulation | |
| US5849704A (en) | Pharmaceutical formulation | |
| CA2086087C (en) | Growth hormone crystals and a process for production of these gh-crystals | |
| US3758683A (en) | Insulin product | |
| DK542089D0 (da) | Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf | |
| NO156010B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, vannopploeselige salter av (+)-katechin. | |
| KR880013572A (ko) | 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도 | |
| IL48122A (en) | Injectable pharmaceutical compositions containing a penicillin derivative and container or syringe therefor | |
| CA1285485C (en) | Nicorandil-containing preparation for injection | |
| ATE25807T1 (de) | Kochsalzersatz-zusammensetzung. | |
| EP0134568A1 (en) | Stable antibacterial lyophilizates | |
| US5780599A (en) | Growth hormone crystals and a process for production of growth hormone crystals | |
| DE3789810D1 (de) | Verfahren zur Herstellung von kristallinem Cefadroxilmonohydrat. | |
| DK148282B (da) | Fremgangsmaade til fremstilling af alkalimetalinsulin | |
| EP0207436A3 (en) | New cytidine-diphosphocholine salts, particularly suitable for oral use | |
| RU2080857C1 (ru) | Способ получения инъекционной формы препарата хондроитинсульфата "хондролон" | |
| US3420810A (en) | Process for joining the a and b chains of insulin | |
| EP0682522B1 (en) | Process to prepare pharmaceutical compositions containing vecuronium bromide | |
| US4235900A (en) | Cephradine compositions | |
| KR880000691B1 (ko) | 세팔렉신의 수용성 유도체의 제조 방법 | |
| SU959786A1 (ru) | Способ консервировани цельной крови | |
| US4130558A (en) | Process for preparation of alkali metal salts of ampicillin | |
| Weil-Malherbe | On the synthesis of cocarboxylase | |
| CA1308358C (en) | Antibacterial lyophilized preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |